12
Views
10
CrossRef citations to date
0
Altmetric
Research Article

Comparison of P-Triglyceride Levels among Patients with Human Immunodeficiency Virus on Randomized Treatment with Ritonavir, Indinavir or Ritonavir/Saquinavir

Pages 306-311 | Published online: 08 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

P. Clevenbergh, R. Garraffo & P. Dellamonica. (2003) Impact of Various Antiretroviral Drugs and Their Plasma Concentrations on Plasma Lipids in Heavily Pretreated HIV-Infected Patients. HIV Clinical Trials 4:5, pages 330-336.
Read now

Articles from other publishers (9)

Bela F. Asztalos, Ernst J. Schaefer, Katalin V. Horvath, Caitlin E. Cox, Sally Skinner, Jul Gerrior, Sherwood L. Gorbach & Christine Wanke. (2006) Protease inhibitor-based HAART, HDL, and CHD-risk in HIV-infected patients. Atherosclerosis 184:1, pages 72-77.
Crossref
Fortino Solórzano Santos, Laura G. Gochicoa Rangel, Gerardo Palacios Saucedo, Guillermo Vázquez Rosales & María Guadalupe Miranda Novales. (2006) Hypertriglyceridemia and Hypercholesterolemia in Human Immunodeficiency Virus-1-Infected Children Treated with Protease Inhibitors. Archives of Medical Research 37:1, pages 129-132.
Crossref
Grace A Lee, Tara Seneviratne, Mustafa A Noor, Joan C Lo, Jean-Marc Schwarz, Francesca T Aweeka, Kathleen Mulligan, Morris Schambelan & Carl Grunfeld. (2004) The metabolic effects of lopinavir/ritonavir in HIV-negative men. AIDS 18:4, pages 641-649.
Crossref
Ole Kirk, Jens D Lundgren, Court Pedersen, Lars R Mathiesen, Henrik Nielsen, Terese L Katzenstein, Niels Obel & Jan Gerstoft. (2002) A Randomized Trial Comparing Initial Haart Regimens of Nelfinavir/Nevirapine and Ritonavir/Saquinavir in Combination with Two Nucleoside Reverse Transcriptase Inhibitors. Antiviral Therapy 8:6, pages 595-602.
Crossref
Michael L. Green. (2002) Evaluation and management of dyslipidemia in patients with HIV infection. Journal of General Internal Medicine 17:10, pages 797-810.
Crossref
Ripamonti Diego, Maggiolo Franco, Arici Claudio & Suter Fredy. (2002) Abacavir-based triple nucleoside therapy versus continued protease inhibitor-based highly active antiretroviral therapy in HIV-1-positive patients. AIDS 16:14, pages 1981.
Crossref
D Worm, O Kirk, O Andersen, J Vinten, J Gerstoft, TL Katzenstein, H Nielsen & C Pedersen. (2002) Clinical lipoatrophy in HIV‐1 patients on HAART is not associated with increased abdominal girth, hyperlipidaemia or glucose intolerance. HIV Medicine 3:4, pages 239-246.
Crossref
Nathan Clumeck, Frank Goebel, Willy Rozenbaum, Jan Gerstoft, Schlomo Staszewski, Julio Montaner, Margaret Johnson, Brian Gazzard, Chris Stone, Rayma Athisegaran & Sarah Moore. (2001) Simplification with abacavir-based triple nucleoside therapy versus continued protease inhibitor-based highly active antiretroviral therapy in HIV-1-infected patients with undetectable plasma HIV-1 RNA. AIDS 15:12, pages 1517-1526.
Crossref
Matthias Egger, Cornelia Junghans, Nina Friis-Møller & Jens D. Lundgren. (2001) Highly active antiretroviral therapy and coronary heart disease: the need for perspective. AIDS 15, pages S193-S201.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.